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Abstract
Background: About 55% of the population 40 to 80 years of age in Barbados is hypertensive. The quality of
hypertension primary care compared to available practice guidelines is uncertain.
Findings: Charts of hypertensive and diabetic patients were randomly sampled at all public and 20 private sector
primary care clinics. Charts of all hypertensive patients ≥ 40 years of age were then selected and processes of care
and blood pressure (BP) maintenance < 140/90 documented.
343 charts of hypertensive patients (170 public, and 173 private) were audited. Patients had the following charac-
teristics: mean age 64 years, female gender 63%, mean duration of diagnosis 9.1 years, and diabetes diagnosed
58%. Patients had an average of 4.7 clinic visits per year, 70% were prescribed a thiazide diuretic, 42% a calcium
channel blocker, 40% an angiotensin receptor blocker, and 19% a beta blocker. Public patients compared to private
patients were more likely to be female (73% vs. 52%, p < 0.01); have a longer duration of diagnosis (11.7 vs. 6.5
years, p < 0.01), and more clinic visits per year (5.0 vs. 4.5, p < 0.01). Over a 2 year period, the proportion of charts
with the following recorded at least once was: BP 98%, weight 80%, total cholesterol 71%, urine tested for albumin
67%, serum creatinine 59%, dietary advice 55%, lipid profile 48%, exercise advice 45%, fasting blood glucose for
non-diabetics 39%, dietician referral 21%, tobacco advice 17%, retinal examination 16%, body mass index 1%, and
waist circumference 0%. Public patients were more likely to have recorded: weight (92% vs. 68%, p = < 0.01); tests
for total cholesterol (77% vs. 67%, p = 0.04), albuminuria (77% vs. 58%, p = < 0.01), serum creatinine (75% vs. 43%,
p < 0.01), and fasting blood glucose for non-diabetics (49% vs. 30%, p = 0.02); dietician referral (34% vs. 9%, p <
0.01), and tobacco advice (24% vs. 10%, p < 0.01). Most (92%) diastolic BP readings ended in 0 or 5 (72% ended
in 0). At the last visit 36% of patients had a BP < 140/90 mmHg.
Conclusions: Improvements are needed in following guidelines for basic interventions such as body mass
assessment, accurate BP measurement, use of thiazide diuretics and lifestyle advice. BP control is inadequate.
Background
Hypertension causes a significant burden of disease in
Barbados, with 55% of the black population 40 to 80
years of age estimated to be hypertensive [1]. Most
hypertension care in Barbados is done by general practi-
tioners either at no cost to the patient in a public sector
polyclinic, or for a fee by a private practitioner. An
appropriate range of medication is available to patients
at no cost in both sectors.
Previous studies estimated that between 17 and 34% of
people being treated for hypertension in Barbados had
their blood pressure controlled to < 140/90 [1-3]. A 1994
audit of 3 public clinics, and 5 private general practi-
tioners showed that 18% of persons being treated for
hypertension had their blood BP controlled to < 140/90,
with this rate being higher in public sector patients [2].
There was no record of lifestyle interventions such as
diet and exercise in the majority of charts, and a poor
quality of BP measurement was indicated by 92% of read-
ings ending in 0 or 5. In an attempt to produce a higher
quality of care the Commonwealth Caribbean Medical
Research Council now called the Caribbean Health
Research Council (CCMRC and CHRC respectively)
developed practice guidelines, Managing Hypertension in
Primary Care in the Caribbean, in 1998 [4]. It was distrib-
uted to all primary care doctors, nurses, and other health
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hypertension in the region, and accompanied (in Barba-
dos) by two seminars for primary care doctors - only a
modest intervention support strategy. All published esti-
mates of BP control have been based on data collected
prior to the release of these guidelines. A revised version
of the CHRC hypertension guidelines was published in
2006, and disseminated in early 2007 [5] again without
strong implementation strategies.
This study was carried out in 2005, prior to the
release of the revised CHRC hypertension guidelines.
The aims of this study were to evaluate the actual status
of care of persons with hypertension in primary care in
Barbados by means of a chart audit, to determine how
closely this care adhered to the 1998 CCMRC guide-
lines, and to provide baseline data to allow the effective-
ness of the 2006 guidelines to be judged in the future.
As patient, practitioner and system barriers to guideline
implementation may differ between the private and pub-
lic health sectors a comparison of guideline adherence
between sectors is made.
Methods
Setting
The population of Barbados was 268,792 at the last cen-
sus in 2000, of which 95.6% were of African origin [6].
The island is 430 km
2, and has a good road network.
Eight public sector polyclinics strategically located
around the island provide free comprehensive primary
care, while in 2005 at least 89 private general practi-
tioners were providing service for a fee. All Barbadians
are entitled to public sector care. Robust data is not
available but it has been estimated that primary care is
approximately equally split between the public and pri-
vate sectors [7].
At public sector polyclinics hypertensive patients are
often seen by a nurse who may record the BP, weight
and urine test results, before the consultation with the
general practitioner. A dietician and podiatrist are avail-
able at each clinic on specific days. All polyclinics have
a pharmacy. Most private practitioners work in solo or
small group practices, and do not employ a nurse. Many
patients seen privately do not have health insurance, but
drugs for the treatment of hypertension are provided
free even to private patients by the Barbados Drug Ser-
vice. Blood pressure is almost exclusively estimated with
mercury sphygmomanometers.
Chart audit instrument
A chart audit instrument was developed to measure the
quality of patient care using indicators recommended in
the Managing Hypertension in Primary Care in the Car-
ibbean guidelines [4]. Indicators used included: each
visit documentation of weight and blood pressure;
annual documentation of urine protein, lipid profile,
fasting blood glucose, creatinine and electrolytes; retinal
assessment every 2 years; and documented maintenance
of BP below 140/90. Since the guidelines recommend
that all BP measurements should be recorded to the
nearest 2 mm/Hg and at least 2 measurements be taken
at each visit, bendrofluazide a thiazide diuretic is the
drug of first choice, and treatment recommendations
include lifestyle modification (diet, exercise, alcohol and
tobacco), indicators to assess adherence to these recom-
mendations were also included. For each patient age,
sex, duration of disease, co-morbidity, medications, and
health care source (private or public sector) were
recorded. No identifying information was collected con-
cerning patients, or health care providers. Data were
collected for a two-year period ending on date of the
last entry into the chart for hypertension. Processes of
care were assessed by noting if they were documented
at least once over a 2-year period. For items recom-
mended to be done yearly, the 2-year interval allowed
for reasonable delays such as return of lab results and
delayed appointments.
A manual explaining the methods of data collection
was developed and 3 primary care nurses were trained
in random chart sampling, and in data collection.
Chart sampling
Inclusion criteria were: at least one visit for hyperten-
sion in the last year by a patient at least 40 years of age;
and hypertension documented in the chart at least 2
years prior to that visit. For the public sector, 100 charts
were selected overall, with the number selected at each
polyclinic in proportion to the number of patients seen
annually by that polyclinic. Private physicians were
selected from a previously validated list containing 89
names and asked to participate in a focus group study
on diabetes and hypertension. At the end of the focus
group session physicians were asked to participate in a
chart audit. Only one refused. An additional 9 physi-
cians who could not attend focus groups because they
were not available at the time the sessions were held
were recruited to make a total of 20 physicians. Since
the annual number of patients seen by individual private
physicians is unknown, the 20 physicians were asked to
contribute 5 charts each. Charts were selected randomly
at the various sites. An equal number of charts of
patients with diabetes mellitus were also selected in the
same way as part of a similar study on diabetes care,
and those who had hypertension were also included in
this study.
Data analysis
Data were coded and double entered into SPSS and
errors corrected. Proportions of cases meeting the
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disease factors associated with meeting these indicators
were determined. With 100 cases from the polyclinics
and the same number from the private sector, propor-
tions of cases meeting the quality indicator can be cal-
culated with a 95% confidence interval of < ± 10% in
each setting, and < ± 7% for both settings combined.
There was > 80% power to detect a 20% difference in
prevalence between the two settings.
Ethical approval
Approval was obtained from the Institutional Review
Board of the University of the West Indies, Cave Hill
Campus and the Ministry of Health, Barbados.
Results
A total of 343 charts of hypertensive patients were
audited (199 selected because the patient was hyperten-
sive and 144 because the patient was diabetic but also
had hypertension), 170 from 8 public polyclinics and
173 from 20 private practitioners. One public clinic con-
tributed 1 less hypertensive chart and 1 less diabetes
chart than the required number.
The mean age of patients was 64 years, the mean dura-
tion of diagnosis was 9.1 years, 63% were female, and
58% were diabetic. Patients had an average of 4.7 clinic
visits per year, 70% were prescribed a thiazide diuretic,
42% a calcium channel blocker, 40% an angiotensin
receptor blocker, and 19% a beta blocker. Patients attend-
ing public clinics were more likely than private patients
to be female; be diagnosed with hypertension for a
greater duration; make more frequent clinic visits; have
vascular disease and osteoarthritis; and to be prescribed
beta blockers. Private physicians were more likely to pre-
scribe angiotensin receptor blockers, and their patients
were significantly heavier. Otherwise the patients at the
two types of clinics were similar (Table 1).
Most patients did not have a recording during a 2-year
period of the following items: physical examination
(height, body mass index (BMI), waist circumference, and
retinal examination); lifestyle (alcohol use, tobacco use and
exercise history or advice); laboratory determination of
fasting glucose (for non-diabetics) and lipid profile; and
referral to a dietician (table 2). Public patients compared
to private patients were more likely to have recorded in
their charts over a 2-year period the following items:
weight, total cholesterol, fasting glucose (for non-
diabetics), electrolytes, serum creatinine, urine albumin
and history and/or advice on alcohol and tobacco use,
and referral to a dietician. Of those on a diuretic,
ACE inhibitor or ARB, 59% had an electrolyte and 62% a
creatinine done in 2 years. For patients without diabetes
60% had a lipid profile, and 71% a total cholesterol in 2
years.
Since weight and blood pressure are recommended to
be taken at each visit, and visits should occur every quar-
ter, according to the guidelines, a patient should have at
least 4 recorded per year or 8 in 2 years (table 3). The
remaining variables in table 3 with the exception of ret-
inal assessment are recommended every year or, on aver-
age, 2 in 2 years. Retinal assessment is recommended
once in every 2 years. Only recording of blood pressure
and urine albumin testing on average, met the target. Pri-
vate patients had, on average, fewer recordings than pub-
lic patients of weight and urine albumin. Seventy two
percent of all blood pressures recorded ended in a 0
(implying rounding to the nearest 10) and 92% ended in
either a 5 or a 0 (implying rounding to the nearest 5 or 0)
although the guidelines recommended rounding to the
nearest 2. For visits at which the BP was recorded, 67%
had only a single reading recorded.
Table 4 indicates the proportion of patients meeting
quality targets. Thirty six percent of patients had their
blood pressure controlled at the last visit to < 140/90.
Few patients met the target frequency for recording of
weight, fasting blood glucose and creatinine, despite
83% having 4 or more visits per year.
Discussion
Barbadian hypertensive patients have adequate access to
physicians with an average of 4.7 clinic visits per year,
but there are significant deficiencies in the frequency
with which several recommended processes of care were
performed - history taking, lifestyle advice, physical
examination, and laboratory tests - and in the achieve-
ment of BP control. Not all factors influencing quality
of care could be measured by this study.
Body mass and lifestyle modification
Height and BMI were recorded in fewer than 4% of
charts even though patients were weighed 2.8 times per
year. Barbadian patients possibly underestimate their
level of overweight and obesity [8] making it imperative
that these additional parameters be measured and dis-
cussed with them. No chart had a recording of waist cir-
cumference, but it should be noted that this was not a
CCMRC 1998 guideline requirement.
There was a poor record of the occurrence of lifestyle
modification such as weight loss, regular physical activ-
ity, and dietary modification which have been shown to
reduce BP [9]. Dietician referral was recorded in 21% of
charts. Whether the low referral rate was due to physi-
cian, patient or system factors could not be determined
by this study. Public sector patients were more likely to
be referred to a dietician than private patients. Differ-
ences in patient characteristics, e.g. public sector
patients were more likely to be female, may explain this.
In addition private patients unlike public patients have
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their doctor’s office.
Blood pressure
On average patients had 4.7 different BPs recorded per
year, representing a significant investment in time for
both health care worker and patient. However almost
all BP readings were rounded to 0 or 5 as in the pre-
vious audit [2], and usually only one reading was
recorded at a clinic visit. This is against guideline
recommendations [4]. An inappropriate excess of
rounding off to 0 has been reported by multiple investi-
gators [10,11], and could be the most common manifes-
tation of sub-optimal BP measurement [12]. Treatment
decisions based on inaccurate readings might result in
less than optimal care. It has been estimated that a sys-
tematic error in under or over-estimating true BP by
5 mm Hg would cause 21 million Americans to be
misclassified as non-hypertensive, and 27 million as
hypertensive respectively [13].
Thirty six percent of patients had a blood pressure <
140/90 mm/Hg, compared to 34% of treated hypertensives
in a randomly selected population cohort studied
from1988 [1]. A 1994 primary care chart audit [2] esti-
mated a control rate of only 18%. However that audit was
restricted to 3 polyclinics and 5 private sector general
practitioners. A similar chart audit restricted to the same
number of clinics and to diabetic patients being treated for
hypertension gave a control rate of 17% [3]. In comparison
the 1999-2002 National Health and Nutrition Examination
Survey estimated that in the USA for patients 40 to 59,
and ≥ 60 years of age, 66% and 48% respectively of those
on treatment are controlled to a BP of < 140/90 mm Hg
[14]. Diastolic pressure was more likely to be controlled
than systolic pressure, reflecting the fact that it is often
more difficult to control the systolic pressure [9].
Table 1 Characteristics of hypertensive patients according to whether they attended public or private clinics (n = 343)
Categorical
Characteristic
Number with
characteristic
Proportion
(%)
Proportion (%) attending
public clinic N = 170
Proportion (%) attending
private clinic N = 173
P value by Chi
Square
Gender:% male 128 38 27 48 < .01
% female 213 63 73 52
Have diabetes* 54 27 27 27 1.00
Have vascular disease 43 13 18 8 < .01
Have heart failure 17 5 6 4 .43
Have osteoarthritis 64 19 27 11 < .01
On thiazide† 240 70 70 70 .99
On indapamide‡ 89 26 24 28 .31
On beta blocker 64 19 23 15 .04
On calcium channel
blocker
145 42 42 42 .98
On ACE inhibitor§ 138 40 39 42 .57
On alpha blocker 14 4 3 5 .29
On centrally acting BP
drug
38 11 13 9 .28
On vasodilator 3 1 1 1 .57
On ARB|| 40 12 6 17 < .01
On statin 79 23 24 22 .64
On aspirin 58 17 16 18 .62
Continuous
Characteristic
Number with valid data Mean (SD) Mean attending public
clinic
Mean attending private
clinic
P value by t-test
Age (years) 342 64(12) 66 63 .08
Weight (kg) 274 82(21) 77 87 < .01
Clinic visits/yr 340 4.7(1.8) 5.0 4.5 < .01
Years since clinic
diagnosis
333 9.1(6.1) 11.7 6.5 < .01
*Includes only the 199 patients included because they were hypertensive, not the 144 who were in the study because they were diabetic but also had
hypertension
†Includes the thiazide like diuretics, indapamide and chlorthalidone
‡Almost exclusively prescribed as a brand name product costing > $0.15 per tablet compared to bendrofluazide at $0.01 per tablet.
§Angiotensin Converting Enzyme
||Angiotensin Receptor Blocker
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according to whether they attended public or private clinic (n = 343 unless otherwise stated)
Recorded process of
care
Number meeting
require-ment
Proportion
(%)
Proportion (%) attending
public clinic N = 170
Proportion (%) attending
private clinic N = 173
P value by Chi
Square
Height recorded* 10 3 2 4 .21
Weight recorded 274 80 92 68 < .01
BMI† recorded 2 1 1 0 .24
WC‡ recorded 0 0 0 0 NA
BP§ recorded 335 98 97 98 .50
Cholesterol done 245 71 77 67 .04
Lipid profile done 166 48 51 46 .31
Fasting glucose done||
n = 145
57 39 49 30 .02
Creatinine done 202 59 75 43 < .01
Electrolytes done
n = 306
176 57 74 42 < .00
Retina assessment
recorded
55 16 15 17 .71
Urine albumin
recorded
231 67 77 58 < .01
Alcohol recorded 66 19 25 13 < .01
Tobacco recorded 58 17 24 10 < .01
Diet advice recorded 187 55 59 50 .11
Referred to dietician 73 21 34 9 < .01
Exercise recorded 153 45 46 43 .64
All BP’s recorded
ended in 0
139 40 44 37 .18
All BP’s recorded
ended in 0 or 5.
261 76 79 73 .24
*Recorded at any time in the chart
†Body Mass Index
‡Waist circumference
§Blood pressure
||Diabetics excluded
Table 3 Means of continuous characteristics of hypertensive patients according to whether they attended public or
private clinic
Characteristic Mean (SD) for all
patients
Mean for public
patients
Mean for private
patients
P value by t
test
Number with valid
data
# hypertension medications 2.1(1.1) 2.1 2.1 .97 343
Total # medications 3.7(1.7) 3.6 3.7 .57 342
# Medication doses/day 4.5(2.6) 4.6 4.4 .55 340
# Weight recorded/yr 2.8(2.0) 3.2 2.2 < .01 342
# Visits with at least 1 BP
recorded/yr
4.4 (1.5) 4.6 4.3 .10 342
# BP done by doctor 2.9(2.2) 1.8 4.1 < .01 342
# Diastolic BP/yr end in 0* 3.4((1.6) 3.7 3.2 < .01 341
# Diastolic BP/yr end in 5* .84(1.2) 0.82 .85 .84 339
# Fasting blood glucoses/yr .95(1.2) 0.87 1.0 .20 335
# Creatinines/2yr 1.1(1.1) 1.4 0.74 < .01 340
# electrolytes/2yr 1.02(1.2) 1.4 0.68 < .00 306
# Cholesterols/2yr 1.2(1.0) 1.3 1.0 < .01 341
# lipid profiles/2yr 1.0(1.1) 1.2 .90 < .01 336
# Retinal assessments/2yr .33(.64) 0.40 .27 .16 197
# urine albumin/2yr 2.5(2.9) 3.2 1.9 < .01 187
*Multiple BPs recorded at a single visit, are counted separately.
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Over 40% of patients did not have a serum creatinine
and electrolytes done in a 2 year period. Similarly 52%
did not have a lipid profile. Cost may be a factor in the
private sector as these 2 tests each cost about US $45.
In the public sector tests are free, but availability may
be a factor for lipid profile testing. The public laboratory
sometimes reports only the total cholesterol if there is
insufficient reagent to complete a profile. The extent to
which this might have been a problem during the study
period is not known. Creatinine and electrolytes are
usually available in both sectors. The public sector did
better than the private sector in testing for proteinuria,
possibly reflecting the fact that private physicians unlike
the public clinics usually do not employ a nurse.
Twenty seven percent of the patients (mean age 64
years) selected on the basis of hypertension were also
diagnosed with diabetes, compared to 18% of a popula-
tion-based cohort (mean age 59 years) [1]. Only 39% of
non-diabetics had a screening fasting blood glucose
done in a 2-year period. It is possible that some had a
random blood glucose as this can be done more easily,
and may be followed by a fasting glucose if equivocal.
Hypertension treatment
T h em o s tf r e q u e n t l yu s e da n t i - h y p e r t e n s i v ea g e n tw a s
the thiazide diuretic. The guidelines [4] recommend
starting patients with this class of drugs. ARB’sw e r en o t
available when the guidelines were produced. The JNC 7
guidelines published in 2003 also recommends that treat-
ment should usually be started with a thiazide diuretic
[9]. It therefore might be expected that even more
patients should have been on this medication, which
costs less than US one cent per day unless brand name
Indapamide (which costs US 15 cents per tablet) is used
[15]. Indapamide was used frequently (37% of patients
taking a thiazide were on indapamide) thus reducing the
cost benefit of using thiazide diuretics. Switching the 89
patients in this study found to be on indapamide to a
generic thiazide would save about US $5000 per year,
and extrapolating to the treated hypertensive population
would save several hundred thousand dollars.
Limitations
Some aspects of the sampling method could have intro-
duced bias. Private physicians were not selected on a
strictly random basis, and as their patient load is
unknown, the quota sampled from each physician could
not be weighted. The distribution of care between pri-
vate and public sectors is also not precisely known. As
the sample included charts of patients who were diabetic
but also had hypertension, a higher proportion of charts
of diabetic patients were audited than if selection was
on the basis of hypertension only (58% vs. 27%). In addi-
tion chart audits are affected by the completeness of the
recording as well as the accuracy with which recorded
measurements are done. Lifestyle measures might be
affected more than other processes by not being
recorded. Inaccurate BP measurement would result in
an inaccurate estimate of BP control.
Conclusions
Despite the creation and distribution of guidelines 6
years before the study period began, a significant gap
Table 4 Proportions of hypertensive patients meeting quality targets* at last visit according to whether they attended
public or private clinic
Target Number
with valid
data
Number
meeting
target
Proportion
(%) meeting
target
Proportion (%)
attending public clinic
who met target
Proportion (%)
attending private clinic
who met target
P value by Chi Square for
difference between public
and private
Systolic BP < 140 335 134 40 43 37 .26
Diastolic BP < 90 335 229 68 64 73 .07
Both Systolic BP <
140 and diastolic
BP < 90
335 121 36 38 35 .59
BP recorded at 4
or more visits/yr
342 265 78 77 78 .85
4 or more weights
recorded/yr
342 134 39 48 31 < .01
2 or more
creatinine
recorded/2yr
340 110 32 40 25 < .01
2 or more
electrolytes
recorded/2yr
306 88 29 36 22 < .00
4 or more visits in
1y r
340 282 83 83 83 .88
*As defined in Managing Hypertension in Primary Care
4
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supports the evidence that guidelines must be accompa-
nied by intensive, multi-pronged implementation efforts
if they are to achieve improved quality of care [16,17].
Improving compliance with guidelines for many of the
recommended interventions may have varying financial
implications, and requires different strategies. Health
care workers have to be provided with the resources
needed to facilitate compliance, and care has to be
affordable to private patients. Some simple office proce-
dures such as measuring height, weight, urine albumin,
taking adequate histories and giving advice cost only the
increase in staff time required to do them. Repetitive
retraining in auscultation, or the use of validated auto-
mated oscillometric BP monitors can reduce the obser-
ver error demonstrated in BP measurement by this
study. Cost effective prescribing might partially balance
the expense of implementing these changes.
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